OAR 340-098-0300: Requirements for a Drug Take-Back Program Plan and Updated Plan
Edition: Current OARD snapshotEffective: 2020-09-21Last verified: 2026-09-07
(1) DEQ may require a proposed drug take-back program plan and updated program plan submitted under ORS 459A.209 to include the Oregon Board of Pharmacy registration number issued for each covered manufacturer participating in the proposed drug take-back program, or a statement that the manufacturer is not required to register with the Oregon Board of Pharmacy. (2) For purposes of ORS 459A.209(4), reasonably convenient and equitable access to all residents includes access for minority, lower-income, rural and other historically underserved communities. (3) A proposed drug take-back program plan and updated program plan submitted under ORS 459A.209 must include a goal for fostering public awareness in minority, lower-income, rural and other historically underserved communities.
Official history and status
Statutory/Other Authority: HB 3273 (2019), ORS 468.020, ORS 468.065, ORS 459A.266 & HB3273 (2019)
Statutes/Other Implemented: HB 3273 (2019), ORS 459A.203, ORS 459A.209, ORS 459A.212, ORS 459A.215, ORS 459A.218, ORS 459A.239, ORS 459A.242 & HB3273 (2019)
History: DEQ 18-2020, adopt filed 09/21/2020, effective 09/21/2020
This rule cites
No citations extracted.
Cited by
Official source: https://secure.sos.state.or.us/oard/